| Dr Richard Lewis Leake, MD | |
|
50 N Medical Dr, Salt Lake City, UT 84132-0001 | |
| (801) 581-7553 | |
| Not Available |
| Full Name | Dr Richard Lewis Leake |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 50 N Medical Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033405485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 9641702-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Cedar City Hospital | Cedar city, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
French trade unions have accused Disneyland in Paris of covering up the death of a swan in the midst of the escalating panic in Europe over bird flu.
Every day that Janet van der Laak drives between car dealerships in her sales job, she keeps size 12 shoes, some clothes and a packed lunch — a PB&J sandwich, fruit and a granola bar — beside her in case she sees her 27-year-old son on the streets.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years-a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation, according to a study today in the Journal of the American College of Cardiology.
› Verified 4 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
French trade unions have accused Disneyland in Paris of covering up the death of a swan in the midst of the escalating panic in Europe over bird flu.
Every day that Janet van der Laak drives between car dealerships in her sales job, she keeps size 12 shoes, some clothes and a packed lunch — a PB&J sandwich, fruit and a granola bar — beside her in case she sees her 27-year-old son on the streets.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years-a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation, according to a study today in the Journal of the American College of Cardiology.
› Verified 4 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
French trade unions have accused Disneyland in Paris of covering up the death of a swan in the midst of the escalating panic in Europe over bird flu.
Every day that Janet van der Laak drives between car dealerships in her sales job, she keeps size 12 shoes, some clothes and a packed lunch — a PB&J sandwich, fruit and a granola bar — beside her in case she sees her 27-year-old son on the streets.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years-a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation, according to a study today in the Journal of the American College of Cardiology.
› Verified 4 days ago
| Entity Name | Tellica Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760197198 PECOS PAC ID: 3577950765 Enrollment ID: O20231201000761 |
News Archive
French trade unions have accused Disneyland in Paris of covering up the death of a swan in the midst of the escalating panic in Europe over bird flu.
Every day that Janet van der Laak drives between car dealerships in her sales job, she keeps size 12 shoes, some clothes and a packed lunch — a PB&J sandwich, fruit and a granola bar — beside her in case she sees her 27-year-old son on the streets.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years-a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation, according to a study today in the Journal of the American College of Cardiology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Lewis Leake, MD Po Box 413033, Salt Lake City, UT 84141-3033 Ph: () - | Dr Richard Lewis Leake, MD 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (801) 581-7553 |
News Archive
French trade unions have accused Disneyland in Paris of covering up the death of a swan in the midst of the escalating panic in Europe over bird flu.
Every day that Janet van der Laak drives between car dealerships in her sales job, she keeps size 12 shoes, some clothes and a packed lunch — a PB&J sandwich, fruit and a granola bar — beside her in case she sees her 27-year-old son on the streets.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years-a higher rate than found in past trials performed to demonstrate the efficacy of the devices in this situation, according to a study today in the Journal of the American College of Cardiology.
› Verified 4 days ago
Dr. Romuald Ferre, Radiology Medicare: Not Enrolled in Medicare Practice Location: University Of Utah Department Of Radiology And Imaging, 30 North Mario Capecchi Drive 2 South, Salt Lake City, UT 84112 Phone: 801-633-7085 | |
Dr. Vilija N Avizonis, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3838 S 700 E, Suite 100, Salt Lake City, UT 84106 Phone: 801-281-6860 Fax: 801-281-4822 | |
Karen Lisa Salzman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Hugh F. Harnsberger, MD Radiology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, 1a71, Salt Lake City, UT 84132 Phone: 801-581-7553 | |
Dr. Jeffrey S Prince, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 N Medical Dr, Salt Lake City, UT 84113 Phone: 801-662-1900 | |
Dr. Erika J. Schneble, DO, MA Radiology Medicare: Accepting Medicare Assignments Practice Location: 30 N 1900 E Rm 1a071, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Dr. Brad Wright, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3321 S 3010 E, Salt Lake City, UT 84109 Phone: 802-310-2843 |